BAYERCROPPesticides & Agrochemicals
Bayer CropScience Ltd — Cash Flow Statement
₹4645.60
-1.50%
Bayer CropScience Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 221.10 Cr | 905.90 Cr | 532.00 Cr | 160.10 Cr | — |
| Capital Expenditure | -40.90 Cr | -45.70 Cr | -77.30 Cr | -55.40 Cr | — |
| End Cash Position | 885.00 Cr | 1.16K Cr | 860.30 Cr | 780.90 Cr | — |
| Beginning Cash Position | 1.16K Cr | 860.80 Cr | 780.90 Cr | 1.20K Cr | — |
| Changes In Cash | -271.80 Cr | 295.70 Cr | 79.40 Cr | -423.60 Cr | — |
| Financing Cash Flow | -619.40 Cr | -656.30 Cr | -613.20 Cr | -703.30 Cr | — |
| Net Other Financing Charges | -1.00 Cr | — | — | — | — |
| Interest Paid Cff | -8.50 Cr | -11.20 Cr | -11.20 Cr | -4.20 Cr | — |
| Cash Dividends Paid | -560.80 Cr | -606.70 Cr | -561.10 Cr | -672.80 Cr | — |
| Investing Cash Flow | 85.60 Cr | 0.40 Cr | 83.30 Cr | 64.20 Cr | — |
| Net Other Investing Changes | 12.50 Cr | 7.70 Cr | 9.20 Cr | 7.00 Cr | — |
| Interest Received Cfi | 46.70 Cr | 30.40 Cr | 25.20 Cr | 20.00 Cr | — |
| Net Investment Purchase And Sale | 66.40 Cr | 1.70 Cr | 10.40 Cr | 23.10 Cr | — |
| Sale Of Investment | 66.40 Cr | 1.70 Cr | 10.40 Cr | — | — |
| Net PPE Purchase And Sale | -40.00 Cr | -39.40 Cr | -72.60 Cr | -47.30 Cr | — |
| Sale Of PPE | 0.90 Cr | 6.30 Cr | 4.70 Cr | 8.10 Cr | — |
| Purchase Of PPE | -40.90 Cr | -45.70 Cr | -77.30 Cr | -55.40 Cr | — |
| Operating Cash Flow | 262.00 Cr | 951.60 Cr | 609.30 Cr | 215.50 Cr | — |
| Taxes Refund Paid | -161.80 Cr | -132.10 Cr | -239.50 Cr | -264.20 Cr | — |
| Change In Working Capital | -355.30 Cr | 33.90 Cr | -140.90 Cr | -406.20 Cr | — |
| Change In Other Current Liabilities | 81.90 Cr | 157.70 Cr | 80.70 Cr | -20.90 Cr | — |
| Change In Other Current Assets | -54.90 Cr | 17.00 Cr | 29.80 Cr | -24.00 Cr | — |
| Change In Payable | 493.30 Cr | -268.10 Cr | 53.30 Cr | -9.70 Cr | — |
| Change In Inventory | -820.80 Cr | 207.20 Cr | -357.90 Cr | -236.40 Cr | — |
| Change In Receivables | -61.90 Cr | 12.90 Cr | 31.30 Cr | -256.30 Cr | — |
| Other Non Cash Items | -79.40 Cr | -37.60 Cr | -123.20 Cr | -78.20 Cr | — |
| Provisionand Write Offof Assets | 76.80 Cr | 7.00 Cr | -4.00 Cr | 5.60 Cr | — |
| Depreciation And Amortization | 84.90 Cr | 74.00 Cr | 79.50 Cr | 64.50 Cr | — |
| Amortization Cash Flow | 2.90 Cr | 1.90 Cr | 1.50 Cr | 0.70 Cr | — |
| Depreciation | 82.00 Cr | 72.10 Cr | 78.00 Cr | 63.80 Cr | — |
| Gain Loss On Investment Securities | -19.10 Cr | -14.80 Cr | -13.50 Cr | -9.40 Cr | — |
| Net Foreign Currency Exchange Gain Loss | 0.40 Cr | -0.30 Cr | 0.80 Cr | -0.50 Cr | — |
| Gain Loss On Sale Of PPE | 1.20 Cr | 6.00 Cr | -0.40 Cr | 2.30 Cr | — |
| Net Income From Continuing Operations | 707.40 Cr | 941.40 Cr | 990.10 Cr | 846.80 Cr | — |
| Common Stock Dividend Paid | — | -606.70 Cr | -561.10 Cr | -672.80 Cr | — |
| Net Business Purchase And Sale | — | 0.00 | 111.10 Cr | 61.40 Cr | 0.00 |
| Sale Of Business | — | 0.00 | 111.10 Cr | 61.40 Cr | 0.00 |
| Repayment Of Debt | — | — | — | 0.00 | -14.00 Cr |
| Issuance Of Debt | — | — | — | 0.00 | 12.50 Cr |
| Net Issuance Payments Of Debt | — | — | — | 0.00 | -1.50 Cr |
| Net Short Term Debt Issuance | — | — | — | 0.00 | -1.50 Cr |
| Short Term Debt Payments | — | — | — | 0.00 | -14.00 Cr |
| Short Term Debt Issuance | — | — | — | 0.00 | 12.50 Cr |
| Dividends Received Cfi | — | — | — | 0.00 | 0.10 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Bayer CropScience Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.